Clinical Trial Update: Efficacy and Safety of Trastuzumab Biosimilars and Pertuzumab Biosimilars Combined With Chemotherapy for Neoadjuvant Treatment of Patients With Locally Advanced HER2-positive Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating trastuzumab biosimilars and pertuzumab biosimilars with chemotherapy as neoadjuvant therapy for locally advanced, HER2-positiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Pertuzumab biosimilar
• Trastuzumab biosimilar

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Rectal Cancer, HER2-positive | Phase 2 | Status: RECRUITING